Anyang-si, South Korea

Jin Soo Lee

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Kyunggi-do, KR (2003)
  • Anyarg-si, KR (2004)

Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: A Closer Look at Inventor Jin Soo Lee

Introduction

Jin Soo Lee is a notable inventor based in Anyang-si, South Korea, with a strong focus on developing innovative compounds in the field of pharmaceuticals. He holds two patents that contribute significantly to antibacterial agents and their efficacy.

Latest Patents

Jin Soo Lee's latest patents include groundbreaking work on optically active quinoline carboxylic acid derivatives featuring 7-pyrrolidine substituents that generate optical activity. The inventions detail processes for the synthesis of these derivatives, which include pharmaceutically acceptable salts and solvates. Notably, these compounds demonstrate superior antibacterial activity and enhanced pharmacokinetic profiles compared to their enantiomers and conventional agents, while exhibiting negligible phototoxicity. This makes the compounds highly valuable for use as antibacterial agents.

Career Highlights

Currently, Jin Soo Lee is affiliated with Dongwha Pharmaceutical Industries Co., Ltd., a company renowned for its commitment to healthcare and drug development. His work here focuses on advancing pharmaceutical research and developing innovative solutions for medical challenges.

Collaborations

Throughout his career, Jin Soo Lee has collaborated with esteemed colleagues, including Sung June Yoon and Yong Ho Chung. These partnerships have further enriched his research endeavors and contributed to the development of effective pharmaceutical products.

Conclusion

In summary, Jin Soo Lee stands out as a remarkable inventor in the pharmaceutical industry. His contributions to developing optically active quinoline carboxylic acid derivatives significantly enhance the potential for new antibacterial treatments. With ongoing collaborations and work at Dongwha Pharmaceutical Industries Co., Ltd., he remains an influential figure in the realm of innovation and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…